The FDA requested additional data regarding rat histology findings from a company, with updates being provided from Dublin.

1 report, 1 independent Updated Jul 23

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Who's involved

What this event is mainly about

FDA

Keep exploring

Part of

GH Research PLC is addressing the FDA's clinical hold on its IND application. All 1 developments

Within A company is conducting clinical trials and seeking drug approval for the U.S. market under the FDA.

The entities involved

FDA
- Generic medicine services are seeking approval for launch from the FDA.Mon 17:49
- A company is seeking FDA feedback on its NEO212 program, with a meeting scheduled at the FDA's White Oak campus.Mon 14:56

Related events

Coverage

Newest first; wire copies grouped

Jul 23GlobeNewswireGH Research Announces Global Pivotal Program Plans and Further Development Updates Engagement with FDA on GH001 IND complete response ongoing The fully completed Open-Label Extension analysis confirm